Dianthus Therapeutics, Inc. (DNTH)

Healthcare · Biotechnology · NASDAQ

Dianthus Therapeutics, Inc. (DNTH) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $5.50B and a free-cash-flow yield of -3.4%. Over the most recent reported fiscal year, revenue declined 67.3%.

Market cap	$5.50B
Trailing P/E	—
FCF yield	-3.4%
Revenue growth (YoY)	-67.3%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live DNTH data on Nama Insights →